CFR > Title 42 > Chapter I > Part 73 > § 73.6. Exemptions for overlap select agents and toxins
Current as of: Oct. 2009
(a) Clinical or diagnostic laboratories and other entities that possess, use, or transfer an overlap select agent or toxin that is contained in a specimen presented for diagnosis or verification will be exempt from the requirements of this part for such agent or toxin contained in the specimen, provided that:
(1) Unless directed otherwise by the HHS Secretary or Administrator, within seven calendar days after identification, the select agent or toxin is transferred in accordance with Sec. 73.16 or 9 CFR part 121.16 or destroyed on-site by a recognized sterilization or inactivation process,
(2) The select agent or toxin is secured against theft, loss, or release during the period between identification of the select agent or toxin and transfer or destruction of such agent or toxin, and any theft, loss, or release of such agent or toxin is reported, and
(3) The identification of the select agent or toxin is reported to CDC or APHIS and to other appropriate authorities when required by Federal, State, or local law.
(i) The identification of any of the following overlap select agents or toxins must be immediately reported by telephone, facsimile, or e-mail: Bacillus anthracis, Brucella melitensis, Hendra virus, Nipah virus, Rift Valley fever virus, or Venezuelan equine encephalitis virus. This report must be followed by submission of APHIS/CDC Form 4 within seven calendar days after identification.
(ii) For all other overlap select agents or toxins, APHIS/CDC Form 4 must be submitted within seven calendar days after identification.
(iii) Less stringent reporting may be required based on extraordinary circumstances, such as a widespread outbreak.
(iv) A copy of APHIS/CDC Form 4 must be maintained for three years.
(b) Clinical or diagnostic laboratories and other entities that possess, use, or transfer an overlap select agent or toxin that is contained in a specimen presented for proficiency testing will be exempt from the requirements of this part for such agent or toxin contained in the specimen, provided that:
(1) Unless directed otherwise by the HHS Secretary or Administrator, within 90 calendar days of receipt, the select agent or toxin is transferred in accordance with Sec. 73.16 or 9 CFR part 121.16 or destroyed on-site by a recognized sterilization or inactivation process,
(2) The select agent or toxin is secured against theft, loss, or release during the period between identification of the select agent or toxin and transfer or destruction of such agent or toxin, and the theft, loss, or release of such agent or toxin is reported, and
(3) The identification of the select agent or toxin, and its derivative, is reported to CDC or APHIS and to other appropriate authorities when required by Federal, State, or local law. To report the identification of an overlap select agent or toxin, APHIS/CDC Form 4 must be submitted within 90 calendar days of receipt of the select agent or toxin. A copy of the completed form must be maintained for three years.
(c) Unless the HHS Secretary issues an order making specific provisions of this part applicable to protect public health and safety, products that are, bear, or contain listed select agents or toxins that are cleared, approved, licensed, or registered under any of the following laws, are exempt from the provisions of this part insofar as their use meets the requirements of such laws:
(1) The Federal Food, Drug, and Cosmetic Act (21 U.S.C. 301 et seq.),
(2) Section 351 of the Public Health Service Act pertaining to biological products (42 U.S.C. 262),
(3) The Act commonly known as the Virus-Serum-Toxin Act (21 U.S.C. 151-159), or
(4) The Federal Insecticide, Fungicide, and Rodenticide Act (7 U.S.C. 136 et seq.).
(d) The HHS Secretary, after consultation with Administrator, may exempt from the requirements of this part an investigational product that is, bears, or contains an overlap select agent or toxin, may be exempted when such product is being used in an investigation authorized under any Federal Act and additional regulation under this part is not necessary to protect public health and safety.
(1) To apply for an exemption, an individual or entity must submit a completed APHIS/CDC Form 5.
(2) The HHS Secretary shall make a determination regarding the application within 14 calendar days after receipt, provided the application meets all of the requirements of this section and the application establishes that the investigation has been authorized under the cited Act. A written decision granting or denying the request will be issued.
(3) The applicant must notify CDC or APHIS when an authorization for an investigation no longer exists. This exemption automatically terminates when such authorization is no longer in effect.
(e) The HHS Secretary may temporarily exempt an individual or entity from the requirements of this part based on a determination that the exemption is necessary to provide for the timely participation of the individual or entity in response to a domestic or foreign public health emergency. With respect to the emergency involved, the exemption may not exceed 30 calendar days, except that one extension of an additional 30 calendar days may be granted. To apply for an exemption or an extension of an exemption, an individual or entity must submit a completed APHIS/CDC Form 5 establishing the need to provide for the timely participation of the individual or entity in a response to a domestic or foreign public health emergency. A written decision granting or denying the request will be issued.
(f) Upon request of the Administrator, the HHS Secretary may exempt an individual or entity from the requirements of this part, for 30 calendar days if the Administrator has granted the exemption for agricultural emergency. The HHS Secretary may extend the exemption once for an additional 30 calendar days.
[70 FR 13316, Mar. 18, 2005, as amended at 73 FR 61366, Oct. 16, 2008]________________________________________________________________________
Questions & Answers: General Health and Prevention
CFR Provisions: General Health and Prevention CFR > Title 42 > Chapter I - Public Health Service, Department Of Health And Human Services | | CFR Title 42 > Chapter I > Part 2 - Confidentiality of alcohol and drug abuse patient records | | CFR Title 42 > Chapter I > Part 2a - Protection of identity--research subjects | | CFR Title 42 > Chapter I > Part 3 - Patient safety organizations and patient safety work product | | CFR Title 42 > Chapter I > Part 5 - Designation of health professional(s) shortage areas | | CFR Title 42 > Chapter I > Part 6 - Federal tort claims act coverage of certain grantees and individuals | | CFR Title 42 > Chapter I > Part 7 - Distribution of reference biological standards and biological preparations | | CFR Title 42 > Chapter I > Part 8 - Certification of opioid treatment programs | | CFR Title 42 > Chapter I > Part 21 - Commissioned officers | | CFR Title 42 > Chapter I > Part 22 - Personnel other than commissioned officers | | CFR Title 42 > Chapter I > Part 23 - National Health Service Corps | | CFR Title 42 > Chapter I > Part 24 - Senior Biomedical Research Service | | CFR Title 42 > Chapter I > Part 31 - Medical care for certain personnel of the Coast Guard, National Ocean Survey, Public Health Service, and former Lighthouse Service | | CFR Title 42 > Chapter I > Part 32 - Medical care for persons with Hansen's disease and other persons in emergencies | | CFR Title 42 > Chapter I > Part 34 - Medical examination of aliens | | CFR Title 42 > Chapter I > Part 35 - Hospital and station management | | CFR Title 42 > Chapter I > Part 37 - Specifications for medical examinations of underground coal miners | | CFR Title 42 > Chapter I > Part 38 - Disaster assistance for crisis counseling and training | | CFR Title 42 > Chapter I > Part 50 - Policies of general applicability | | CFR Title 42 > Chapter I > Part 51 - Requirements applicable to the protection and advocacy for individuals with mental illness program | | CFR Title 42 > Chapter I > Part 51a - Project grants for maternal and child health | | CFR Title 42 > Chapter I > Part 51b - Project grants for preventive health services | | CFR Title 42 > Chapter I > Part 51c - Grants for community health services | | CFR Title 42 > Chapter I > Part 51d - Mental health and substance abuse emergency response procedures | | CFR Title 42 > Chapter I > Part 52 - Grants for research projects | | CFR Title 42 > Chapter I > Part 52a - National Institutes of Health center grants | | CFR Title 42 > Chapter I > Part 52b - National Institutes of Health construction grants | | CFR Title 42 > Chapter I > Part 52c - Minority Biomedical Research Support Program | | CFR Title 42 > Chapter I > Part 52e - National Heart, Lung, and Blood Institute grants for prevention and control projects | | CFR Title 42 > Chapter I > Part 52h - Scientific peer review of research grant applications and research and development contract projects | | CFR Title 42 > Chapter I > Part 53 - Grants, loans and loan guarantees for construction and modernization of hospitals and medical facilities | | CFR Title 42 > Chapter I > Part 54 - Charitable Choice regulations applicable to States receiving Substance Abuse Prevention and Treatment block grants and/or Projects for Assistance in Transition from Homelessness grants | | CFR Title 42 > Chapter I > Part 54a - Charitable Choice regulations applicable to States, local governments and religious organizations receiving discretionary funding under Title V of the Public Health Service Act, 42 U.S.C. 290aa, et seq., for substance abuse prevention and treatment servic | | CFR Title 42 > Chapter I > Part 56 - Grants for migrant health services | | CFR Title 42 > Chapter I > Part 57 - Grants for construction of teaching facilities, educational improvements, scholarships and student loans | | CFR Title 42 > Chapter I > Part 59 - Grants for family planning services | | CFR Title 42 > Chapter I > Part 59a - National Library of Medicine grants | | CFR Title 42 > Chapter I > Part 60 - Health Education Assistance Loan Program | | |
U.S. Code Provisions: General Health and PreventionState Laws: General Health and Prevention
 |
Email
Print